Showing 271-280 of 538 results for "".
How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivThe Role of GLP-1RAs in Treating Inflammatory Dermatologic Diseases
https://practicaldermatology.com/issues/novemberdecember-2025/the-role-of-glp-1ras-in-treating-inflammatory-dermatologic-diseases/48899/Herein, we review the benefits and risks of GLP-1RAs with a focus on these 3 chronic inflammatory conditions.Calcium Dependence of the SHH Pathway and Theoretical Implications in Oral Treatment of Locally Advanced or Metastatic Basal Cell Carcinomas
https://practicaldermatology.com/issues/supplements/calcium-dependence-of-the-shh-pathway-and-theoretical-implications-in-oral-treatment-of-locally-advanced-or-metastatic-basal-cell-carcinomas/21719/HZ Masquerading as Periorbital Cellulitis Following Mohs Surgery; AMA Focuses on Physician Well-being, Suicide Prevention
https://practicaldermatology.com/youngmd-connect/resident-resource-center/hz-masquerading-as-periorbital-cellulitis-following-mohs-surgery-ama-focuses-on-physician-well-being-suicide-prevention/20374/ASDS Updates
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/asds-updates/23823/The American Society for Dermatologic Surgery shined in Colorado for the first live annual meeting post pandemic.Teledermatology Use during the COVID-19 Pandemic
https://practicaldermatology.com/columns/clinical-focus-1/teledermatology-use-during-the-covid-19-pandemic/23769/Despite challenges, the future of teledermatology is promising.Vitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.Reassessing Topical 5-Fluorouracil for AK Management
https://practicaldermatology.com/topics/practice-management/reassessing-topical-5-fluorouracil-for-ak-management/21021/New research highlights the beneficial role of this therapeutic mainstay, alone and in combination with lesion-directed treatment.Thin Melanomas: When is SLN Biopsy Indicated?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thin-melanomas-when-is-sln-biopsy-indicated/20805/New research offers additional evidence that mitotic rate may have a role in clinical decision-making.Understanding the Legalities of Off-label Use
https://practicaldermatology.com/topics/practice-management/understanding-the-legalities-of-off-label-use/20317/Off-label use is part and parcel of dermatology practice, but confusion about the practice persists. Here's what you should know.